McKesson, Illinois Department of Healthcare and Family Services Report $262 Million Net Savings in Program's Fourth Year

Administered by McKesson, the care management program improves the health and wellness of more than 280,000 Medicaid beneficiaries throughout the state by providing personalized telephonic and community-based registered nurse services. HFS and McKesson launched the multi-disciplinary care management program in July 2006 to help disabled adult Illinois Medicaid beneficiaries, and children with asthma and their caregivers, who are part of the Family Health Medicaid program.

By helping beneficiaries better control chronic diseases, Your Healthcare Plus saved the state $262 million during year four (July 2009-June 2010). Net savings for years one through four is:

With more than $4.4 billion of actual claims costs during the four years, Your Healthcare Plus generated a total net savings of $569 million.

“Your Healthcare Plus is a tremendously successful care management program. Our nurse and healthcare staff use their expertise and knowledge of the community to guide participants to the most appropriate health resources. This includes talking with our telephonic or community-based staff, or taking advantage of community resources. By utilizing available resources, Medicaid beneficiaries better control acute and chronic illnesses, and drive cost savings for the state,” said Emad Rizk, M.D., president, McKesson Health Solutions.

Clinical indicators improve: baseline to year four

Through the program, McKesson’s care coordination services – the ability to help participants find and use the most appropriate resources – ensure Medicaid beneficiaries access the care needed to improve clinical indicators. Improving these indicators can directly affect a participant’s overall health and wellness.

Across all managed disease states, the program reported an average 15% improvement in influenza vaccinations from baseline (July 2005-June 2006) to year four. Your Healthcare Plus care coordination supported improvement, baseline to year four, for participants with heart failure, COPD, diabetes, coronary artery disease and asthma:

For participants with heart failure and/or COPD:

• 15% improvement in rate of beta blocker medication use in heart failure
• 41% improvement in spirometry testing in COPD
• 21% improvement in reported rate of vaccination for pneumococcal infections (pneumonia) in heart failure and COPD

For participants with diabetes:

• 36% improvement in retinal eye examinations
• 11% improvement in testing for kidney damage
• 10% improvement in aspirin use
• 11% improvement in statin (cholesterol lowering medication)
• 9% improvement in cholesterol testing

For participants with coronary artery disease:

• 9% improvement in statin (cholesterol lowering medication)
• 8% improvement in cholesterol testing
• 26% improvement in reported rate of vaccination for pneumococcal infections (pneumonia)

For participants with asthma:

• 20% improvement of use of written action plans for persons with asthma

About McKesson

McKesson Corporation, currently ranked 15th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information, visit http://www.mckesson.com .

PR Contact

McKesson Health Solutions
Jordan Gruener, Public Relations Manager, 303-664-6410